Stock Analiz

Codexis, Inc. CDXS

Major Chemicals · IPO 2010 · data as of November 13, 2026

$1.16Market cap $127M
Open the interactive analysis →

Codexis, Inc. (CDXS) is a industrial company listed in the US with a market value of about $127M. In the twelve months to September 30, 2026 it had revenue of $88M and net income of -$19M, a net margin of -21.8%.

Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is future growth (3/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of 0% a year, a 5-year average ROIC of -28%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 98% below the current price.

About Codexis

Codexis is listed in the US and classified in major chemicals, IPO year 2010. Revenue went from $35M in 2014 to $70M in 2025, growth of about 6.5% a year. It was profitable in 0 of the last 10 years in our data. Its share count rose by 33% over three years (dilution for shareholders). It spends 74% of revenue on research and development.

Score: 0.8 / 5

Value0/5
Future growth3/5
Track record0/5
Financial health1/5
Shareholder returns0/5

Checks passed

  • Revenue growth above 10% last year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • More cash than debt, or low debt to equity

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S1.4
P/B2.5
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-9.6%
Shareholder yield0.0%
Intrinsic value vs. price−98%

Growth and quality

Revenue growth (1 yr)18.6%
Revenue growth (5 yrs, per year)0.4%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-65.1%
ROIC (5-yr avg.)-27.7%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 10 years

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$88M$70M$59M$70M$139M$105M$69M$68M$61M$50M$49M
Net income-$19M-$44M-$65M-$76M-$34M-$21M-$24M-$12M-$11M-$23M-$9M
Free cash flow-$12M-$24M-$54M-$57M$3M-$28M-$20M-$16M-$17M-$10M-$3M
EPS (diluted)$-0.19$-0.50$-0.89$-1.12$-0.51$-0.33$-0.40$-0.21$-0.21$-0.50$-0.21
Net margin-21.8%-62.5%-110.0%-108.7%-24.2%-20.3%-34.8%-17.4%-17.9%-46.0%-17.5%
ROIC—-26.7%-36.4%-52.4%-14.6%-8.5%-9.7%-7.5%-20.0%-73.0%-44.6%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 7 analysts is $6.14, 430% above the current price; targets range from $2.00 to $11.00; the consensus rating is “Buy”; expected EPS is $-0.42 for the fiscal year ending December 31, 2026.

Frequently asked questions

Is Codexis stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 98% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Codexis pay a dividend?

Not currently.

Is Codexis a good stock to buy?

We do not give buy or sell advice. Codexis scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.